Marc Lore Uses AI and Blood Tests for Meals
According to Business Insider, Marc Lore said on Semafor's podcast that he has used artificial intelligence plus a blood test to choose every non-restaurant meal for the past year. Business Insider reports Lore said the AI planned his breakfasts, lunches, and dinners and helped keep his blood biomarkers in check. Per Business Insider's reporting, Lore said he hopes to run a beta test of the system at his food-hall chain Wonder this fall. Business Insider also reports Wonder has opened roughly 120 locations and acquired Grubhub and Blue Apron; Wonder did not respond to a request for comment, Business Insider writes.
What happened
According to Business Insider, Marc Lore said on Semafor's podcast that he has relied on artificial intelligence plus a blood test to direct every non-restaurant meal for the past year. Business Insider reports Lore said, "When I'm not eating at a restaurant, every meal I eat is AI-directed." Business Insider reports the model planned his breakfasts, lunches, and dinners and, per Lore, "was able to keep me healthy, and keep my blood biomarkers in check." Business Insider reports Lore said he hopes to roll out a beta test of the model at Wonder food halls this fall. Business Insider reports Wonder has opened roughly 120 locations and has acquired Grubhub and Blue Apron; Business Insider writes that Wonder did not respond to a request for comment.
Editorial analysis - technical context
Systems that personalise diets from biomarkers typically combine clinical or consumer blood measures, feature engineering to map biomarkers to dietary inputs, and ML models that recommend meals. For practitioners, the key technical challenges in similar projects include integration of lab-standard biomarker data, label scarcity for long-term outcomes, and building recommendation models that balance nutritional goals with user preferences.
Industry context
Industry observers note growing commercial interest in biomarker-driven nutrition and food-delivery integration, where firms attempt to turn personalized recommendations into delivered meals. Scaling a model from a single user's regimen to a food-hall or delivery product commonly requires operationalizing menu-to-nutrition mappings, real-time inventory alignment, and quality controls that meet both regulatory and consumer-safety expectations.
What to watch
- •Adoption signals: whether Wonder begins a public beta and the size/demographics of test cohorts.
- •Data inputs and privacy: whether the offering uses clinical lab tests, at-home tests, or continuous monitors, and what consent/data-governance practices are published.
- •Measured outcomes: any published metrics on biomarker changes, adherence, or clinical validation will be crucial for practitioner assessment.
Reported sources
All factual claims in this summary are drawn from Business Insider's reporting of Marc Lore's appearance on Semafor's podcast and related coverage in the Business Insider article.
Scoring Rationale
This story matters to practitioners because it highlights a real-world founder trial of biomarker-driven personalization and a planned product beta. It is notable for operational and data-integration implications but not a technical breakthrough or new open model.
Practice interview problems based on real data
1,500+ SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems


